US Traffic Fatalities, 1985–2014, and Their Relationship to Medical Marijuana Laws by Santaella Tenorio, Julian et al.
US Traffic Fatalities, 1985–2014, and Their
Relationship to Medical Marijuana Laws
Julian Santaella-Tenorio, DVM, MSc, Christine M. Mauro, PhD, Melanie M. Wall, PhD, June H. Kim, MPhil, MHS, Magdalena Cerdá, DrPH,
Katherine M. Keyes, PhD, Deborah S. Hasin, PhD, Sandro Galea, MD, DrPH, and Silvia S. Martins, MD, PhD
Objectives.To determine the association ofmedicalmarijuana laws (MMLs)with traffic
fatality rates.
Methods. Using data from the 1985–2014 Fatality Analysis Reporting System, we
examined the association between MMLs and traffic fatalities in multilevel regression
models while controlling for contemporaneous secular trends. We examined this as-
sociation separately for each state enacting MMLs. We also evaluated the association
between marijuana dispensaries and traffic fatalities.
Results.On average, MML states had lower traffic fatality rates than non-MML states.
Medical marijuana laws were associated with immediate reductions in traffic fatalities in
those aged 15 to 24 and 25 to 44 years, and with additional yearly gradual reductions in
those aged 25 to 44 years. However, state-specific results showed that only 7 states
experienced post-MML reductions. Dispensaries were also associatedwith traffic fatality
reductions in those aged 25 to 44 years.
Conclusions. Both MMLs and dispensaries were associated with reductions in traffic
fatalities, especially among those aged 25 to 44 years. State-specific analysis showed
heterogeneity of theMML–traffic fatalities association, suggestingmoderation by other
local factors. These findings could influence policy decisions on the enactment or
repealing of MMLs and how they are implemented. (Am J Public Health. Published online
ahead of print December 20, 2016: e1–e7. doi:10.2105/AJPH.2016.303577)
In the past 2 decades, 23 US states and theDistrict of Columbia have enacted laws
allowing the use of cannabis (marijuana) to
treat certain medical conditions.1 Despite
potential benefits of legislation protecting
the medical use of marijuana, concern is
increasing that medical marijuana laws
(MMLs) may increase nonmedical marijuana
use and the number of individuals driving
under the influence of marijuana, and thus
increase the rate of traffic injuries.2
Some simulator and on-road experimental
studies show a dose-dependent association
between marijuana exposure and several
indicators of driving impairment.3 Studies
show that marijuana exposure is associated
with increased response time and lane
weaving.4,5 In addition, it has been associ-
ated with impairment in other complex tasks
requiring neurocognitive and neuromotor
skills6,7 that are likely to be involved in
driving safely. Marijuana exposure has also
been associated with reduced speed and
greater headway,4,8 which indicates some
degree of awareness of marijuana-related
impairment and a tendency to compensate.8
Despite these observations, population-
based data have not shown an increase in
traffic fatalities followingmedical marijuana
legalization. A study that used 1990–2010
Fatality Analysis Reporting System (FARS)
data showed that, contrary to expectations,
MML enactment was associated with
a reduction in the rates of traffic fatalities in
the overall population (10.4% reduction),
mainly because of a reduction in alcohol-related
traffic fatalities.9 These findings suggest that
MML enactment could have contributed to
an increase in marijuana use and lowered the
use of alcohol, consistentwith the substitution
hypothesis,10 in these states, partially
explaining the reduced alcohol-related
incidents observed.
Previous research11 also shows that
MMLs are heterogeneous across states, and
that certain aspects of these laws, such
as allowances on home cultivation or dis-
pensaries, might be important to take into
account when one is assessing the association
between MMLs and different health out-
comes. For example, a previous study
showed that authorization of dispensaries
in MML states was associated with treatment
admissions in which marijuana is the primary
substance of abuse.11 One study to date
has found evidence of dispensary legal
provisions in MML states to be associated
with an increase in traffic fatalities,12 but
the study did not examine the association
between the actual presence of operational
dispensaries (i.e., having an operating
dispensary system even if not officially
sanctioned) and traffic fatalities. Examining
the role of operational dispensaries would
provide additional information on whether
increases in marijuana availability via dis-
pensaries lead to changes in fatality rates.
We investigated the association between
MML enactment and change in traffic fatal-
ities,making use of awider range of the FARS
data, years 1985 to 2014, and including 9
additional states enacting MMLs between
2010 and 2014. We examined whether the
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rate of traffic fatalities changed following
MML enactment in 1985 to 2014, if the
magnitude of the association differed by state,
and if estimateswere robust to differentmodel
specifications and to the inclusion of potential
confounders in the model. In addition, we
explored the specific role of operational
medical marijuana dispensaries on traffic
fatality rates.
METHODS
Data came from the FARS, a nationwide
census of traffic fatalities information
maintained by theNational Highway Traffic
Safety Administration. Briefly, this data
set provides data on individuals fatally in-
jured in motor vehicle crashes on public
roads in the United States who died within
30 days of the crash.13 Data include driver
characteristics such as age, gender, and race.
We obtained the aggregated FARS data
from different sources including police
accident reports, death certificates, coroner
or medical examiner reports, hospital
medical reports, state highway department
data, emergency medical services records,
vital statistics, and other state records.13
Trained analysts collected the data by using
standardized protocols that automatically
check for acceptable range values and
consistency.13 We used FARS data from
years 1985 to 2014, enabling us to include at
least 10 years of pre-MML data for all states
enacting these laws. We did not include
the District of Columbia in the analyses.
Measures
Traffic fatalities. Our outcome of interest
was the rate of traffic fatalities across time.
We obtained the total number of fatally
injured road users, including drivers, pas-
sengers, cyclists, and pedestrians, by year,
state, and age group (entire population, and
those aged 15–24, 25–44, and ‡ 45 years)
from FARS. We obtained state populations
for each year, state, and age group used to
calculate fatality rates for each state from the
Web-based Injury Statistics Query and
Reporting System of the Centers for Disease
Control and Prevention.14 In analyses for
the entire population, we used age-adjusted
traffic fatality rates based on the 2000 US
population.
Enactment and effective date of medical
marijuana laws. Our main exposure was the
enactment of MMLs by state, as defined
by legal scholars, economists, and policy an-
alysts at RAND Corporation15 (Table A,
available as a supplement to the online version
of this article at http://www.ajph.org). First,
we coded theMML variable as a time-varying
(i.e., allowed to change over time), 3-category
variable. The 3 categories were before, after,
and never. States enacting medical marijuana
laws were coded as “before” for the years
before the enactment of the laws, and as “after”
for years after. For example, because Vermont
enacted its MML in 2004, this state is coded as
“before” for years 1985 to 2003 and as “after”
for years 2004 to 2014. As MMLs are enacted
in different months, if the law was enacted
between January 1 and June 30, we coded the
year of MML enactment as “after,” because
the state was exposed to the MML for at least
half of the year in which it was enacted. Al-
ternatively, if the MML was enacted between
July 1 and December 31, we coded the year of
MML enactment as “before,” because the
state was exposed to the MML only for the
second half of the year. States without MMLs
up to 2014were coded as “never” for all years.
We also used the datewhenMMLs became
effective, when the statutory obligation
commences in each state, rather than the date
enacted.We used the same coding strategy as
the one used for enactment dates.
Operational dispensaries. We coded the
presence of operational dispensaries in MML
states as a time-varying, 3-category variable in
a similarway aswe did for ourMMLvariable—
before, after, and never—on the basis of pre-
vious11,16 and recent information provided by
researchers at RANDCorporation. States with
MMLs were coded as “before” for years before
they had operational dispensaries, and were
coded as “after” for years when the state had
legally operating dispensaries. This is when
legislation was passed allowing marijuana sales
and also an operational regulatory and distri-
bution regime,16 or if the state had a functional
dispensary system, even if not officially sanc-
tioned16 (Table A). States without dispensaries
were coded as “never” for all years.
Covariates. We adjusted our analyses for
time-varying state characteristics and
state legislation used in previous research.9
State-level covariates included unemployment
rate and median household income, speed
limits of 70 miles per hour or greater,17
primary seat belt laws enforcement, laws
decriminalizing the possession of small
amounts of marijuana, and whether states
had enacted a recreational marijuana law.18,19
The later 4 covariates were coded as “1”
if the state had the law in any given year
and “0” otherwise. We also controlled for
state-level graduated driver license laws,20
blood alcohol content laws (0.08 g/dL), drug
per se laws,21 administrative license revo-
cation laws,22 and laws banning cell phone
use and texting while driving, separately
targeting adolescents and adults.23 These
later 5 covariates were coded as “1” if the
state had the law in any given year and “0”
otherwise; also, if the enactment of the law
occurred during a calendar year, we coded
that year as the proportion of the year the
law was in effect. In addition, we included
a measure of state annual expenditures for
highway law enforcement and safety per
capita (adjusted to 2000 dollars), and also
a state measure of the annual vehicle miles
driven per licensed driver (thousands of miles)
from Highway Statistics, US Department of
Transportation (both covariates log transformed).
Because alcohol consumption can be
a confounder of the association between
MML and traffic fatalities, we also explored
the robustness of estimates when we con-
trolled for a measure of the state-level per
capita ethanol sales, total ethanol of all
beverages combined per population aged
21 years or older (log transformed) from the
Surveillance Reports of the National Institute
on Alcohol Abuse and Alcoholism. Results are
presented in Table B, available as a supplement
to the online version of this article at http://
www.ajph.org. However, because changes in
ethanol sales could be a mechanism through
which MML influences traffic fatalities, all re-
sults provided, except when indicated, are from
models not including this covariate.
Statistical Analyses
To examine whether MMLs were associ-
ated with changes in the natural logarithm
of the rate of traffic fatalities, we used linear
multilevel regression models24 with state-level
random intercepts. This main effect model,
which used the 3-category MML as the
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exposure variable, allowed us to determine the
change in the rate of fatalities within states
before and after MML enactment (Figure 1:
overall change, model 1) while taking into ac-
count the rates in states that didnot enactMMLs.
In addition, we used a piecewise cubic spline25
with a knot at 2007 to control for the non-
linearity of national trends in traffic fatality rates;
this allowedus to control for any national events
that could have influenced traffic fatality rates
across states over time.Allmodelswere stratified
by age group, weighted by the state population,
and adjusted for covariates. The percent change
in fatality rates associated with the enactment
of MMLs was estimated with the equation,
(1) % change= (1—exp[estimate difference
between pre/post MML rates]) · 100%.
To estimate the yearly variation in the
rates of traffic fatalities after the enactment
of MMLs, we used an alternative model
strategy by including linear trends for years
before and after the enactment of MML
for states with these laws.26 In this “hybrid”
model, the estimate for the 3-categoryMML
variable represents the “immediate” change
in the rate soon after MMLs are enacted,
and the “trend” effect represents the change
in the linear trend, from the pre-MML to the
post-MML period26 (Figure 1). The hybrid
model can be useful to identify a change
in the trend in cases such as the one presented
in Figure 1, when a marked decreasing trend
in traffic fatalities in the pre-MML period
is followed by an immediate reduction and
then by a gradual increasing trend in traffic
fatalities in the post-MML period. In this
scenario, the main effect model would show
an overall reduction in traffic fatalities as-
sociatedwithMML despite the change in the
trend. The pattern in Figure 1 could emerge
if, for example, the enactment of MML is
followed by stronger police enforcement
soon after the enactment that would result in
an immediate reduction in traffic fatality
rates; however, a possible gradual increase in
the prevalence of marijuana use after en-
actment of MMLs could result in a gradually
increasing prevalence of driving while
intoxicated, leading to a gradual increase
in traffic fatalities.
We also examined the association between
operational dispensaries and traffic fatalities by
using similar models as described previously
adjusted by covariates and also by the time-
variant MML variable indicating whether
states had or had not enacted MMLs.
Finally, we examined the state-specific
association between MMLs and traffic
fatalities in the entire population (i.e., all
ages) by including state as a fixed effect in
models, both in the main effect and hybrid
models, with interaction terms (1) between
MML and states, and (2) between pre–
post-MML trends and states; in this model
we dichotomized the MML variable as
“1” in years in which states had a MML, and
“0” otherwise. This provided us the before–
after comparison and the change in trends
separately for each state that passed
MMLs. We performed statistical analysis
with SAS version 9.4 (SAS Institute Inc,
Cary, NC).
RESULTS
A total of 1 220 610 deaths attributable
to traffic crashes occurred in the 50 states
during the study period (1985–2014). We
observed a reduction in the age-adjusted
(2000 US population) national rate of traffic
fatalities from 1985 (17.8 per 100 000) to
2014 (10.0 per 100 000). Although, on
average, states enacting MMLs had lower
rates of traffic fatalities compared with states
without MMLs (26.3% lower; 95% confi-
dence interval [CI] = 13.9%, 36.9%) states
with and without MMLs followed a similar
trend pattern toward reductions in traffic
fatality rates (Figure 2). Among individuals
aged 24 to 44 years, the trend for states
enacting MMLs before 2001 slightly de-
viated during 1996 to 2000, the period in
which these states enacted theirMMLs, from
that of states enacting MMLs after 2001.
Medical Marijuana Law Enactment
and Traffic Fatality Rates
Results from main effect models for the
entire population (i.e., all ages) showed that,
among states passing MMLs, the mean
traffic fatality rate in the pre-MML period
(12.1 per 100 000) was significantly higher
than that in the post-MML period (11.2 per
100 000), indicating a reduction of 10.8%
(95% CI=9.0%, 12.5%; % reduction= [1 –
exp(–0.114)] · 100) in traffic fatality rates
(Table 1). Similarly, we observed a reduction
of 11.0% (95% CI = 8.5%, 13.5%), 12.0%
(95% CI = 9.5%, 14.3%), and 9.0% (95%
CI = 6.9%, 11.0%) among those aged 15 to
24 years, 25 to 44 years, and 45 years and
older, respectively (Table 1).
In hybrid models for the entire population,
the immediate effect (i.e., sudden change in
fatality rate after MML enactment), indicated
that there was an immediate reduction of
3.5% (95% CI= 1.1%, 5.8%), whereas the
gradual effect (i.e., change in rate trend after
MML enactment) was not significant (Table
1). For those aged 15 to 24 and 25 to 44 years,
there were also similar immediate reductions
in traffic fatalities as those observed in the
entire population. Among those aged 25 to
44 years, the gradual effect was also negative
and significant (difference in pre–post MML
trends= –0.005; P< .01). We observed no
significant reductions among those aged
45 years or older in hybrid models (Table 1).
Enactment of MML










Note. MML=medical marijuana law.
FIGURE 1—Model Estimates With a Main Effect Model Strategy (Model 1) andWith a Hybrid
Model Including Immediate andTrendEffects (Model 2) to Examine theAssociationBetween
Medical Marijuana Laws and Traffic Fatalities, United States, 1985–2014
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Operational Dispensaries and
Traffic Fatality Rates
Results from main effect models showed
that dispensaries were associated with a sig-
nificant reduction in traffic fatalities in those
aged 25 to 44 years (5.1%; 95% CI= 1.5%,
8.6%), and a nonsignificant reduction in the
entire population (2.7%; 95% CI= –0.01%,
5.3%; Table 1). In hybrid models, the im-
mediate effect and gradual effects were not
significant for any of the age groups (Table 1).
In the main effect models, further control
for the state-level per-capita ethanol sales
(log transformed) covariate reduced the
magnitude of the association between MMLs
and traffic fatalities by 20% to 22% across
age groups, although estimates remained
significant at a 95% confidence level (Table
B). Hybrid models were not impacted by
the inclusion of this ethanol sales covariate.
Results for the association between
“MML effective date” variable and traffic
fatality rates were almost identical to those
described previously for the “MML en-
actment date” variable (Table C, available as
a supplement to the online version of this
article at http://www.ajph.org).
Estimates for Individual States
Results from the main effect model
show that in 7 states (California, Oregon,
Washington, Colorado, Nevada, New
Mexico, and Arizona) the MML enactment
was significantly associated with a reduction in
traffic fatality rates, whereas in 2 states (Rhode
Island and Connecticut) MMLs were associ-
ated with an increase in rates (Table 2).
In hybrid models, only 4 states showed
significant associations: California showed an
immediate post-MML reduction of 16.0%
in traffic fatalities (95% CI = 12.0%, 20.0%)
followed by a gradual yearly increase
(difference in pre–post-MML trends= 0.013;
P< .01); similarly, New Mexico had an im-
mediate post-MML reduction of 17.5% (95%
CI= 1.4%, 31.0%) and significant post-MML
gradual increase in traffic fatalities (difference
in pre–post-MML trends = 0.049; P< .01);
Colorado had a nonsignificant immediate
increase and a yearly significant reduction in
fatality rates (difference in pre–post-MML
trends = –0.022; P < .05); and Michigan had
a positive immediate increase of 14.2% in
traffic fatalities (95% CI = 4.7%, 24.5%) and
a nonsignificant trend effect (Table 2).
DISCUSSION
Using population-based data from 1985
to 2014, we found that, first, states that
enacted MMLs during the study period had
lower fatality rates compared with states
without MMLs. Second, on average,
traffic fatalities further decreased in states
post-MML, with both immediate (sudden
change in fatality rate afterMML enactment)
and gradual (change in rate trend after MML
enactment) declines over time in those
aged 25 to 44 years. Third, the association
between MML and traffic fatalities
varied considerably across states. Fourth,
the presence of operational dispensaries
was also associated with reductions in
traffic fatalities in those aged 25 to 44 years.
We found that, on average during the
study period, MML states had lower traffic
fatality rates than non-MML states. It is
possible that this is related to lower levels of
alcohol-impaired driving behavior in MML
states. Evidence from the Behavioral Risk
Factor Surveillance Systems data from
200027 and 201228 shows that states that have
enacted MMLs, compared with non-MML
states, had, on average, lower proportions
or rates of drivers endorsing having driven
after having too much to drink. In addition,
other unmeasured characteristics, including
strength of public health laws related to
driving, infrastructure characteristics (e.g.,
high-technology roads), or quality of
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1985 1990 1995 2000 2005 2010 2014
Year
States without MML by 2015
States enacting MML before 2001
States enacting MML after 2001
a b
Note. MML=medical marijuana law. Linear trends (estimate and P value). Group aged 15–24 years: states without MMLs by 2015 (–0.75; P< .001); states enacting MMLs
before 2001 (–0.88;P < .001); and states enactingMMLs after 2001 (–0.76;P < .001). Group aged25–44 years: stateswithoutMMLs by 2015 (–0.20;P < .001); states enacting
MMLs before 2001 (–0.40; P < .001); and states enacting MMLs after 2001 (–0.28; P < .001). Figures for all age groups are provided in Figure A, available as a supplement
to the online version of this article at http://www.ajph.org.
FIGURE 2—Traffic Fatality Rates Across States Enacting Medical Marijuana Laws and Those Without Medical Marijuana Laws by 2014 Among
Those Aged (a) 15–24 Years and (b) 25–44 Years: United States, 1985–2014
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Our study also shows that, on average,
MMLs were associated with an overall re-
duction in traffic fatalities in main effect
models. In addition, in hybrid models, we
found immediate and gradual reductions
only among those aged 25 to 44 years,
a group representing a great percentage of
all registered patients for medical marijuana
use,29 and a group showing increases in the
prevalence of marijuana use in association
with the enactment of MMLs.30 In-
terestingly, we did not find strong evidence
suggesting reductions among those aged
45 years and older, which is also a group
overrepresented in the population of patients
registered in state medical marijuana pro-
grams.29 This suggests that the mechanisms
by which MMLs reduce traffic fatalities
mostly operate in those younger adults,
a group also frequently involved in alcohol-
related traffic fatalities; in 2004 and 2013,
47% of fatally injured drivers with a blood
alcohol content of 0.08 or greater were aged
25 to 44 years.31
There may be different mechanisms by
which MMLs may reduce traffic fatalities.
Some evidence suggests9 that MMLs may
increase marijuana use in the population
and, consistent with the substitution hy-
pothesis,10 reduce the prevalence of alcohol
consumption that, in turn, would result
in lower rates of alcohol-related traffic fa-
talities. Anderson et al.9 found reductions
in traffic fatalities in which at least 1 driver
was positive for any alcohol in the blood
(marginally, P < .1) and those with blood
alcohol concentrations greater than or equal
to 0.1 grams per deciliter (P < .05), and also
reductions in traffic fatality rates occurring
on weekends, which are more likely to
be alcohol-related than those on weekdays.
If MMLs reduce traffic fatalities by re-
ducing alcohol-related deaths, it is expected
that these reductions would have been
gradual given that MMLs are likely to
gradually increase the availability of mari-
juana as dispensaries are opened and the
number of patients getting access to medical
marijuana increases, for example, as de-
scribed for patient registries across MML
states.29 However, immediate reductions
may also occur if the enactment of MMLs
produces rapid changes in attitudes toward
marijuana use in the overall population,
reducing perceptions of risk associated with
marijuana use. In addition, immediate
reductions can be the result of stronger
preventive police enforcement actions
targeting weekend drivers occurring soon
after the enactment ofMMLs. In this regard,
because few registered patients for medical
marijuana are aged 15 to 24 years29 and
also because MMLs had not been found
to be associated with marijuana use in in-
dividuals aged 25 years or younger30 nor
in adolescents,32,33 it is possible that the
immediate reduction we observed in the
hybrid model for those aged 15 to 24 years is
related to external control measures, such
as stronger police enforcement actions.
Our findings for specific state associations
suggest that not all MML states experienced
reductions in traffic fatality rates, but few
actually experienced increases. Although
results from main effects models suggest
beneficial reductions in traffic fatalities for
7 states, in the hybrid model, only Colorado
showed a significant yearly reduction in
traffic fatalities. In California and New
Mexico, after an initial immediate reduction,
MMLs were actually associated with gradual
increases in fatality rates. These findings
provide evidence of the heterogeneity of
MML–traffic fatalities associations across
states and indicate the need for further
research on the particularities of MML
implementation at the local level and the
interaction of MMLs with other aspects
that may influence traffic fatality rates.
Finally, results from our operational dis-
pensaries analyses, at least from the main
effect model, support the initial findings that
MMLs were associated with reductions in
traffic fatalities among those aged 25 to 44
years and suggest that this may in part occur
via increases in marijuana availability.
Limitations
Limitations are noted. First, we described
an overall association between MMLs and
traffic fatalities, but we are uncertain of what
the causal chain may be. This study adds to
TABLE 1—Estimate of the Association Between the Enactment of State Medical Marijuana
Laws,Operational Dispensaries, and States’Traffic FatalityRates (Natural Logarithm)byAge
Group: United States, 1985–2014
Rate Differencea (95% CI)
Effect Age 15–24 Years Age 25–44 Years Age ‡ 45 Years All Ages
Medical
marijuana laws




–0.059 (–0.095, –0.023) –0.040 (–0.075, –0.006) –0.020 (–0.048, 0.008) –0.036 (–0.060, –0.011)
Trend effect 0.002 (–0.002, 0.005) –0.005 (–0.009, –0.002) –0.0001 (–0.003, 0.003) –0.001 (–0.004, 0.001)
Operational
dispensaries




0.008 (–0.038, 0.055) –0.002 (–0.047, 0.043) 0.016 (–0.019, 0.052) 0.014 (–0.017, 0.046)
Trend effect 0.007 (–0.0004, 0.014) –0.005 (–0.012, 0.017) –0.0001 (–0.006, 0.006) –0.001 (–0.006, 0.004)
Note. CI = confidence interval; MML=medical marijuana law. All models are adjusted by the national
trend of vehiclemiles driven per licensed driver and the following state-level covariates: population size,
unemployment rate, median household income, speed limits of 70 mph or greater, primary seat belt
enforcement laws, graduated driver license laws, blood alcohol content laws, drug per se laws,
administrative license revocation laws, highway law enforcement and safety expenditures, de-
criminalization of marijuana laws, recreational marijuana laws, bans on texting and cell phone use while
driving laws targeting adolescents and adults, and annual miles driven per licensed driver. All models
weremultilevel random intercept regressionmodelswith random intercepts for states and a cubic form
of time with a piecewise linear spline with a knot at 2007.
aLog scale.
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evidence of the association between MMLs
and traffic fatalities, laying the groundwork
for future studies on specific mechanisms.
Moreover, our data suggest that one
mechanism is through increases in marijuana
availability as dispensaries become
operational. Second, because we used
state-level aggregate data, we could not
observe whether associations vary across
different cities or counties. However, our
study provides state-level estimates, the
level at which MMLs are enacted. Further
research at local levels will improve our
understanding of howMML aspects and also
other factors relate to traffic fatalities.
Third, we did not examine other vari-
ations in medical marijuana laws (e.g.,
home cultivation, approved illnesses) in
our models that could also have an effect on
traffic fatalities. However, we examined
the additional effect of operational dis-
pensaries, an important factor increasing
the availability of marijuana. Fourth, for
states enacting MMLs after 2010, we had
only short post-MML periods, which
limited the identification of long-term
effects in these states.
Fifth, we could not examine whether
MMLs were associated with increments in
the rates of traffic fatalities in which drivers
tested positive for the presence of cannabis
metabolites in blood. Testing procedures
vary by state and our own exploration of
FARS data showed that only a limited
number of states tested 80% or more of their
fatally injured drivers. In addition, the FARS
coding system does not differentiate be-
tween active and inactive cannabinoid
metabolites34 and, therefore, it is not possible
to know whether the driver was driving
under the influence of marijuana. Sixth, we
used data on traffic fatalities, the most ex-
treme injury outcome; therefore, we cannot
make any observations on the association
between MMLs and nonfatal traffic injuries.
Finally, our measure of per-capita al-
cohol consumption may not fully capture
varying alcohol consumption patterns in
the population, and is not informative about
specific age groups. However, per-capita
alcohol consumption data have moderate
to strong correlations with survey measures
of drinking, heavy drinking, and binge
drinking,35 and this indicator of overall
alcohol consumption in the United States
has been a long-term National Institutes of
Health indicator of time trends in drinking.
Implications
Our study suggests that, on average, MMLs
are associated with reductions in traffic fa-
talities, particularly pronounced among
those aged 25 to 44 years, a group repre-
senting a great percentage of all registered
patients for medical marijuana use,29 and
with increased prevalence of marijuana use
TABLE 2—Estimate of the Association Between the Enactment of State Medical Marijuana





MML on Traffic Fatality Rates,
Model 2, Hybrid Model
State 1985 2014
MML on Traffic Fatality Rates,





California 17.95 7.72 –0.199** (0.014) –0.175** (0.024) 0.013** (0.004)
Oregon 20.6 8.5 –0.226** (0.037) –0.053 (0.067) 0.008 (0.008)
Washington 16.59 6.34 –0.217** (0.030) –0.008 (0.054) 0.0002 (0.007)
Alaska 23.42 9.93 –0.116 (0.083) 0.168 (0.152) –0.007 (0.018)
Maine 17.12 9.16 0.035 (0.058) 0.048 (0.106) 0.002 (0.012)
Colorado 17.57 8.95 –0.068* (0.032) 0.089 (0.059) –0.022* (0.007)
Nevada 26.75 10.08 –0.198** (0.054) 0.003 (0.089) 0.008 (0.010)
Hawaii 11.6 6.55 0.040 (0.059) 0.019 (0.108) –0.013 (0.013)
Maryland 15.74 7.34 0.001 (0.03) 0.028 (0.052) –0.003 (0.007)
Montana 27.1 18.92 0.052 (0.071) –0.020 (0.125) –0.011 (0.019)
Vermont 20.91 6.44 –0.122 (0.086) 0.050 (0.153) 0.003 (0.022)
Rhode Island 10.4 4.44 0.179* (0.070) 0.111 (0.121) 0.011 (0.021)
New Mexico 36.24 18.58 –0.243** (0.053) –0.193* (0.091) 0.049** (0.018)
Michigan 16.7 8.85 0.0001 (0.027) 0.132** (0.044) 0.021 (0.013)
New Jersey 12.29 5.99 0.023 (0.030) 0.077 (0.048) –0.010 (0.017)
Arizona 27.47 11.17 –0.195** (0.039) –0.029 (0.060) –0.024 (0.028)
Delaware 15.92 12.59 0.103 (0.101) –0.044 (0.159) 0.040 (0.075)
Connecticut 13.19 6.8 0.169** (0.062) 0.162 (0.088) –0.024 (0.060)
Massachusetts 11.81 4.67 –0.020 (0.055) 0.034 (0.069) 0.027 (0.088)
Summarya
Increase—significant 2 1 2
Reduction—significant 7 2 1
Increase—not significant 7 10 9
Reduction—not significant 3 6 7
Note. MML=medical marijuana law. Model 1: linear regression model with interaction term between
MML and state, adjusted by a cubic form of time with a piecewise linear spline with a knot at 2007, and
covariates.Model 2: linear regressionmodel with interaction terms betweenMML and state, interaction
terms between pre–post-MML trends and states, and adjusted by a cubic form of time with a piecewise
linear splinewith a knot at 2007, and covariates. All models are adjusted by the national trend of vehicle
miles driven per licensed driver and the following state-level covariates: population size, unemployment
rate, median household income, speed limits of 70mph or greater, primary seat belt enforcement laws,
graduated driver license laws, blood alcohol content laws, drug per se laws, administrative license
revocation laws, highway lawenforcement and safety expenditures, decriminalizationofmarijuana laws,
recreationalmarijuana laws, bans on texting and cell phone usewhile driving laws targeting adolescents
and adults, and annual miles driven per licensed driver.
aIn the summary section, significance is based on P < .05.
*P < .05; **P < .01.
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after the enactment of MMLs.30 Although
increases in marijuana use following the es-
tablishment of marijuana dispensaries could
reduce the occurrence of alcohol-related
mortality by reducing the number of drivers
driving under the influence of alcohol, other
simultaneous factors at the state and local
levels alsomay be responsible for these changes
in traffic fatalities. Our findings show great
heterogeneity of the MML–traffic fatalities
associations across states, suggesting the
presence of these other mechanisms. This is
important for policy development and for
the debate of the enactment or repealing of
MMLs, given that alternative local strategies
such as stronger police enforcement and
programs aiming to reduce impaired driving
involving any substance use could be local
factors linked to reductions in traffic fatalities
in MML states.
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